Fibroblast Growth Factor-23 and Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS)

BACKGROUND: Fibroblast growth factor-23 (FGF-23) is a hormone that promotes urinary phosphate excretion and regulates vitamin D metabolism. Circulating FGF-23 concentrations increase markedly in chronic kidney disease and are associated with increased risk of clinical cardiovascular events. FGF-23 m...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Mathew, Jehu S., Sachs, Michael C., Katz, Ronit, Patton, Kristen K., Heckbert, Susan R., Hoofnagle, Andrew N., Alonso, Alvaro, Chonchol, Michel, Deo, Rajat, Ix, Joachim H., Siscovick, David S., Kestenbaum, Bryan, de Boer, Ian H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4108550/
https://ncbi.nlm.nih.gov/pubmed/24920722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.113.005499
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia